European Journal of Medicinal Chemistry · 2013 · 28 citations · 21 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryCell Cycle PharmacologyEnzyme InhibitionMelanocytic TumorsRetrosynthetic AnalysisAntiproliferative AgentsAntiproliferative Drug ActionCheckpoint Kinase InhibitionQuinoline AlkaloidsQuinoline ChemistryQuinoline SynthesisTargeted Kinase InhibitionTyrosine Kinase Inhibition
21
Scott M. Wilhelm, Christopher Carter, LiYa Tang et al. · Cancer Research · 2004 · 4K citations · Full text
Medicine, Oncology, Pharmacology +17
BRAF and RAS mutations in human lung cancer and melanoma.
Marcia S. Brose, Patrícia Volpe, Michael D. Feldman et al. · PubMed · 2002 · 1K citations
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis
Tim Eisen, T. Ahmad, Keith T. Flaherty et al. · British Journal of Cancer · 2006 · 636 citations · Full text
Medicine, Oncology, Pharmacology +15
Prognostic factors in 1,521 melanoma patients with distant metastases.
Andreas S. Barth, Leslie A. Wanek, D L Morton · PubMed · 1995 · 573 citations